Загрузка...
Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer
OBJECTIVES: Gonadotropin-releasing hormone agonists are widely used as androgen deprivation therapy in many men with locally advanced or metastatic prostate cancer. Gonadotropin-releasing hormone agonists are delivered by intramuscular injection every 1, 3 or 6 months, but in some patients subcutane...
Сохранить в:
| Опубликовано в: : | Ther Adv Urol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485417/ https://ncbi.nlm.nih.gov/pubmed/26161143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215577329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|